Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
about
Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infectionHepatitis C virus and neurological damageExtrahepatic manifestations of chronic hepatitis C virus infectionCutaneous manifestations of hepatitis C in the era of new antiviral agentsBenign and Malignant Hematological Manifestations of Chronic Hepatitis C Virus InfectionThe place of immunotherapy in the management of HCV-induced vasculitis: an updateTreatment of Hepatitis C in Patients Undergoing Immunosuppressive Drug TherapyHepatitis C Therapy in Renal Patients: Who, How, When?Hepatitis C virus infection in nephrology patientsDecreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.Peg-IFNα/ribavirin/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24Managing refractory cryoglobulinemic vasculitis: challenges and solutionsA case of rapid amelioration of hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis treated by interferon-free directly acting antivirals for HCV in the absence of immunosuppressantHepatitis C virus associated glomerulopathies.Detection of low level cryoglobulins by flow cytometry.Hepatitis C and kidney disease: An overview and approach to management.Hepatitis C-related arthropathy: Diagnostic and treatment considerations.A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis.An additional line of therapy with pegylated interferon and ribavirin after rituximab in a patient with hepatitis C virus-related mixed cryoglobulinaemia and indolent non-Hodgkin's lymphoma previously treated with interferonHepatitis C virus as a multifaceted disease: a simple and updated approach for extrahepatic manifestations of hepatitis C virus infectionSuccessful and Safe Long-Term Standard Antiviral Therapy in a Patient with "Explosive" Immune Response in Course of HCV-Related Liver CirrhosisIndolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents.Hepatitis C virus, cryoglobulinemia, and kidney: novel evidence.New insights into HCV-related rheumatologic disorders: A review.An approach to the patient with retiform purpura.Laboratory testing for cryoglobulins.Update on the role of rituximab in kidney diseases and transplant.Rituximab in immunologic glomerular diseases.Management of rheumatic disease with comorbid HBV or HCV infection.Current treatment of hepatitis C-associated rheumatic diseasesAntiviral therapy for HCV-associated cryoglobulinemic glomerulonephritis: case report and review of the literature.Viral hepatitis: review of arthritic complications and therapy for arthritis in the presence of active HBV/HCV.Antiviral therapy of symptomatic HCV-associated mixed cryoglobulinemia: meta-analysis of clinical studies.Hepatitis C virus-induced vasculitis: therapeutic options.Membranoproliferative glomerulonephritis, type II cryoglobulinemia and triple therapy for hepatitis C: a case series and review of the literature.Vasculitides and the Complement System: a Comprehensive Review.Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.Extrahepatic manifestations in chronic hepatitis C virus carriers.Combined treatment with antiviral therapy and rituximab in patients with mixed cryoglobulinemia: review of the literature and report of a case using direct antiviral agents-based antihepatitis C virus therapy.
P2860
Q24187162-7637D3A2-3C3D-42E1-980D-033670182D83Q26748575-F6131206-2FC9-4F85-90C5-C4DEE6A99F15Q26767084-19177BED-1A93-413E-B83B-DEE99CD707E5Q26773669-C3C995EE-CB9C-46AC-AA8C-C16B89FEE7EFQ26775733-F450A0F3-5380-40B7-9B33-336F885048C6Q27015124-DC7FD5E6-1D5B-4D2A-BB7D-A13CF2B0364DQ28073100-AA34A9B7-B961-4767-B807-185F5E7B7D1FQ28077130-F42EEC3C-8FC4-4B65-9BA0-30739FD7567BQ30486664-DDFC1385-F240-4987-BA5B-204F7ABBD318Q33403052-109DDEBA-3615-439E-A48E-9BBFFBD4242EQ33407192-082349F8-C079-4261-ABB9-04F524EE7CDAQ33673888-8B8B2BA8-DAF4-48DC-984A-84FE70F47D10Q33710278-34F21FA5-A3FD-4902-B127-1B6E23AD58A7Q33801278-428AE28B-A204-4176-99F0-3282CA899C83Q34409505-75EA7805-E371-43D6-A4A6-FE74D9ACBA41Q34966853-D93221BF-F493-4097-9143-1DB10FE35D0BQ35010720-3363687A-0CB2-446B-9B18-92F590CA099EQ35624871-2DBBE88E-535C-4305-B03C-74E471D293B9Q35674649-CB8D3417-7FE1-407F-85A4-63087405C7C9Q35731058-F3ADA5EC-D219-47A6-8D48-C679B937C78DQ35814151-78CAE515-9546-4DDA-83B4-C791461B3A6FQ36204525-1FFCF10E-3952-4DF1-B88D-376B5ABB4CB8Q36479541-C1D8FA7B-49DB-4BC9-8C93-6FADCB7EF894Q37288114-FDDF30B5-127F-463A-8194-4FF53E00FB67Q37610871-8B57E3C2-61A2-4FAE-849F-71669592EEE6Q37853593-68BD47B3-AE40-4DA4-9529-72CB012ED382Q37877205-07B2BC24-3078-4A6F-8EEC-4C1EBCC4C7DEQ37970443-5F415744-9FB3-4891-B3EB-424D00346775Q37989298-E7280EA6-9539-438E-9FDE-E3550104C8E8Q38008173-D9BF339F-9BC8-44BC-B89C-AD41577CE8B0Q38021493-8B2EB675-87A3-4843-987F-D799ED4CC402Q38073147-761CD8DB-4AFB-47D0-BAFB-B707DF94454FQ38084182-356FB0F3-E88D-468D-AB2D-B6315367CEC1Q38099226-D8A3F693-208A-446F-8B62-871FF6C6E163Q38127143-3F64CF8D-627E-4A24-AA0A-BAC9192F5F26Q38196327-768618AB-DD96-4752-8AE8-70265C35EFC3Q38259908-5523EDBC-67FB-4978-B480-8454464316E6Q38298448-26DCBECD-2C23-4E2A-917E-0FEECA4D5467Q38388423-FBAF760E-2939-4F9F-B15F-6A60A02A49ABQ38393228-F1623B5E-494D-46B4-B11A-F1F3DDA595BD
P2860
Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferon-alpha/ribavirin in hepatitis C-related mixed cryoglobulinemia.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.
@en
Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.
@nl
type
label
Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.
@en
Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.
@nl
prefLabel
Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.
@en
Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.
@nl
P2093
P50
P1433
P1476
Rituximab plus Peg-interferon- ...... elated mixed cryoglobulinemia.
@en
P2093
Alexandre Karras
Benjamin Terrier
Brigitte Coppéré
Damien Sene
David Saadoun
François Blanc
Laurent Perard
Lucile Musset
Mathieu Resche Rigon
Yoland Schoindre
P304
326-34; quiz 504-5
P356
10.1182/BLOOD-2009-10-248518
P407
P577
2010-05-03T00:00:00Z